摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-bromo-3'-chloro-2'-methylacetophenone | 1368683-20-8

中文名称
——
中文别名
——
英文名称
2-bromo-3'-chloro-2'-methylacetophenone
英文别名
2-Bromo-1-(3-chloro-2-methylphenyl)ethan-1-one;2-bromo-1-(3-chloro-2-methylphenyl)ethanone
2-bromo-3'-chloro-2'-methylacetophenone化学式
CAS
1368683-20-8
化学式
C9H8BrClO
mdl
——
分子量
247.519
InChiKey
XWXBXCYMHSYYGI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

文献信息

  • [EN] OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO )ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES<br/>[FR] ANTAGONISTES DES RÉCEPTEURS DE L'OREXINE, QUI SONT DES DÉRIVÉS [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO )ARYL)-PYRROLIDIN-1-YL]-METHANONE
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2014057435A1
    公开(公告)日:2014-04-17
    The present invention relates to [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]- methanone derivatives of formula (I) wherein R, and the rings A1 A2 and A3 are as described in the description, to pharmaceutically acceptable salts thereof, to their preparation, to pharmaceutical compositions containing one or more compounds of formula (I), and to their use as pharmaceuticals, especially to their use as orexin receptor antagonists.
    本发明涉及公式(I)中的[ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-甲酮衍生物,其中R和环A1、A2和A3如描述中所述,以及其药用盐,其制备方法,含有一个或多个公式(I)化合物的药物组合物,以及它们作为药物的用途,特别是作为促进睡眠荷尔蒙受体拮抗剂的用途。
  • Method for the in situ preparation of chiral compounds derived from oxazaborolidine-borane complexes which are used in asymmetric reduction reactions
    申请人:Burgos Alain
    公开号:US20070055068A1
    公开(公告)日:2007-03-08
    A process for the in situ preparation of chiral compounds derived from oxazaborolidine-borane complexes, wherein a metal borohydride, a Lewis base and an inorganic acid ester are brought together and an optically active amino alcohol and optionally a halide are then added. The compound obtained is a complex that is useful as a catalyst in asymmetric reduction reactions. The reaction is performed by adding the substance to be reduced, particularly prochiral ketones or ether oximes, in order to synthesize chiral alcohols or chiral amines.
    一种用于原位制备从氧杂硼烷硼酸盐复合物中衍生的手性化合物的方法,其中将氢化物、路易斯碱和无机酸酯混合,然后加入手性活性基醇和可选的卤化物。所得化合物是一种复合物,可用作不对称还原反应中的催化剂。通过将待还原物质,特别是原始手性酮或醚加入以合成手性醇或手性胺来执行反应。
  • OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI-(HETERO-)ARYL]-[2-(META BI-(HETERO-)ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:US20150252032A1
    公开(公告)日:2015-09-10
    The present invention relates to [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives of formula (I) wherein R, and the rings A 1 A 2 and A 3 are as described in the description, to pharmaceutically acceptable salts thereof, to their preparation, to pharmaceutical compositions containing one or more compounds of formula (I), and to their use as pharmaceuticals, especially to their use as orexin receptor antagonists.
    本发明涉及公式(I)的[ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone衍生物,其中R和环A1A2和A3如描述中所述,以及其药学上可接受的盐、其制备方法、含有一个或多个公式(I)化合物的制药组合物以及它们作为药物的用途,特别是作为促进睡眠激素受体拮抗剂的用途。
  • Process for producing optically active carbinols
    申请人:SUMIKA FINE CHEMICALS Company, Limited
    公开号:EP0713848A1
    公开(公告)日:1996-05-29
    The present invention relates to a process for producing optically active halomethyl phenyl carbinols of the formula (1), comprising reducing halomethyl phenyl ketones of the formula (2) using an asymmetric reducing agent obtained from boranes and optically active α-phenyl-substituted-β-amino alcohols of the formula (3) or optically active α-non-substituted-β-amino alcohols of the formula (4). The present invention further relates to a process for producing optically active carbinols, comprising reacting with an unsymmetric ketone, an asymmetric reducing agent obtained from optically active β-amino alcohols of the formula (5), a metal boron hydride and Lewis acid or lower dialkyl sulfuric acid.
    本发明涉及一种生产光学活性的式(1)卤代甲基苯基甲醇的工艺,包括使用从硼烷和光学活性的式(3)α-苯基取代-β-基醇或光学活性的式(4)α-非取代-β-基醇中得到的不对称还原剂还原式(2)卤代甲基苯基酮。 本发明还涉及一种生产光学活性烷醇的工艺,包括与不对称酮、从式(5)光学活性β-基醇中得到的不对称还原剂、氢化物路易斯酸或低级二烷基硫酸反应。
  • Processes for preparing optically active alcohols and optically active amines
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:EP0736509A2
    公开(公告)日:1996-10-09
    A process for preparing an optically active alcohol by reacting a prochiral ketone corresponding to the optically active alcohol and an acid with a mixture of (1) a boron-containing compound selected from the group consisting of i) a borane compound which is obtained from an optically active β-aminoalcohol and a boron hydride; or obtained from the optically active β-aminoalcohol, a metal borohydride and an acid and ii) an optically active oxazaborolidine and (2) a metal borohydride; and a process for preparing an optically active amine by reacting an oxime derivative and an acid with a mixture of (1) a boron-containing compound selected from the group consisting of i) a borane compound which is obtained from an optically active β-aminoalcohol and a boron hydride, or obtained from said optically active β-aminoalcohol, a metal borohydride and an acid and ii) an optically active oxazaborolidine, and (2) a metal borohydride.
    一种制备光学活性醇的工艺,其方法是将对应于光学活性醇的手性酮和酸与(1)选自以下组别的含化合物和(2)选自以下组别的含化合物的混合物反应:①从光学活性β-基醇和氢化中得到的硼烷化合物;或从光学活性β-基醇、氢化物和酸中得到的硼烷化合物;②光学活性噁唑硼烷和(2)氢化物;以及一种制备光学活性胺的工艺,其方法是使生物和酸与(1)一种含化合物与(2)一种氢化物的混合物反应,该含化合物选自以下组别:(1)一种硼烷化合物,该硼烷化合物由光学活性β-基醇和氢化物得到,或由所述光学活性β-基醇、氢化物和酸得到;以及(2)一种光学活性噁唑硼烷和(2)一种氢化物
查看更多